[1]WANG FS,FAN JG,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.
|
[2]Experts in combined team of the major special project of Ministry of Science and Technology supported by China's"Twelfthfive-Yearplan".Management of clinical diagnosis,evaluation,and antiviral therapy for HBV-related cirrhosis[J].Chin J Hepatol,2014,22(5):327-335.(in Chinese)科教部十二五重大专项联合课题组专家.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华肝脏病杂志,2014,22(5):327-335.
|
[3] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[4]FAN ST.Liver functional reserve estimation:state of the art and relevance for local treatments:the Eastern perspective[J].J Hepatobiliary Pancreat Sci,2010,17(4):380-384.
|
[5]MARTINOT-PEIGNOUX M,CARVALHO-FILHO R,LAPALUS M,et al.Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-nave,e antigen-positive patients[J].J Hepatol,2013,58(6):1089-1095.
|
[6]DONG AA,ZHAO J,JIA JW,et al.Quantitative detection of HBs Ag for evaluation of liver function in patients with chronic hepatitis B[J].World Chin J Dig,2012,20(31):3033-3036.(in Chinese)董爱爱,赵洁,贾建伟,等.HBs Ag定量检测在慢性HBV感染患者肝脏储备功能评价中的作用[J].世界华人消化杂志,2012,20(31):3033-3036.
|
[7] LUO KX.Hepatitis B basic biology and clinical science[M].4th ed.Beijing:People's Medical Publishing House,2012:41,224.(in Chinese)骆抗先.乙型肝炎基础和临床[M].4版.北京:人民卫生出版社,2012:41,224.
|
[8]NGUYEN T,THOMPSON AJ,BOWDEN S,et al.Hepatitis B surface antigen levels during the natural history of chronic hepatitis B:a perspective on Asia[J].J Hepatol,2010,52(4):508-513.
|
[9]LIN LY,WONG VW,ZHOU HJ,et al.Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeA g-negative patients[J].J Med Virol,2010,82(9):1494-1500.
|
[10]WURSTHOM K,LUTGEHETMANN M,DANDRI M,et al.Peginterferon alpha-2b plus adefovir induce strong ccc DNA decline and HBs Ag reduction in patients with chronic hepatitis B[J].Hepatology,2006,44(3):675-684.
|
[11] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,CMA;Severe Liver Diseases and Artificial Liver Group,Chinese Society of Hepatology,CMA.Guideline for diagnosis and treatment of liver failure(2012 version)[J].Chin J Clin Infect Dis,2012,5(6):321-327.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.
|
[12]LIU YR,FAN ZP,YANG W,et al.Clinical evaluation of liver storage function by indocyanine green retention test[J].Chin J Hepatol,2010,18(6):476-477.(in Chinese)刘义荣,范作鹏,杨薇,等.吲哚菁绿滞留测试对肝储备功能的评价[J].中华肝脏病杂志,2010,18(6):476-477.
|
[13]HAN ZQ,ZHU ZH,JI BJ.Prothrombin time,prealbumin,cholesterol,and cholinesterase in patients with severe hepatitis[J].Mod J Integr Tradit Chin West Med,2003,12(23):2591.(in Chinese)韩志启,朱增红,冀宝剑.重症肝炎患者凝血酶原时间、前白蛋白、胆固醇、胆碱酯酶的观察[J].现代中西医结合杂志,2003,12(23):2591.
|
[14]YANG PL,AITHAGE A,CHUNG J,et al.Immune effectors required for hepatitis B virus clearance[J].Proc Natl Acad Sci U S A,2010,107(2):798-802.
|